Floatz logo

cp-690,550

Psoriasis

PfizerPhase 3Dormant
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
64/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Psoriasis cohort.

Asset / SponsorPhaseRating
1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER
Amgen
Phase 4BBB
Calcipotriene
Hospital Universitario Dr. Jose E. Gonzalez
Phase 4BBB
Tirzepatide
Eli Lilly and Company
Phase 4BBB
Semaglutide
Hospital Universitario Dr. Jose E. Gonzalez
Phase 4BBB
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A)), HOMO SAPIENS MONOCLONAL ANTIBODY
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4BB

View all 24 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →